STRO · Sutro Biopharma, Inc.

$23.40 +0.40 (+1.74%) At close · Jul 22

Market Cap

$387.75M

16.57M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	CEO	$239,693	—	—	—	—	$1,431,618	$1,671,311
Jane Chung	CEO	$652,000	—	$167,400	$245,280	$465,750	$45,500	$1,575,930
Hans-Peter Gerber	Chief Scientific Officer	$527,532	—	$61,425	$110,127	$243,818	—	$942,902
Gregory Chow	CFO	$277,083	$25,000	$88,000	$245,938	$218,500	—	$854,522

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	CEO	$707,500	—	$758,180	$589,373	$277,290	—	$2,332,343
Jane Chung	CEO	$560,000	—	$454,000	$169,360	$182,000	$78,000	$1,443,360
Hans-Peter Gerber	Chief Scientific Officer	$512,500	$100,000	$204,300	$203,232	$133,900	—	$1,153,932

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	CEO	$496,500	—	—	$3,097,200	$223,425	—	$3,817,125
Trevor J. Hallam	President of Research and Chief Scientific Officer	$418,000	—	—	$330,600	$150,480	$132,000	$1,031,080
Arturo Molina	Chief Medical Officer	$453,500	—	—	$330,600	$163,260	—	$947,360

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	CEO	$482,000	—	$1,136,355	$6,764,993	$301,250	—	$8,684,598
Trevor J. Hallam	President of Research and Chief Scientific Officer	$405,800	—	$702,465	$2,951,998	$202,900	$132,000	$4,395,163
Arturo Molina	Chief Medical Officer	$440,300	—	$387,390	$2,306,240	$220,150	—	$3,354,080

Key facts CIK 1382101 CUSIP 869367201 13F (30d) 4 filings 4 filers Visit website Investor relations